{"id":"W2970201384","doi":"10.1093/eurheartj/ehz404","title":"Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"Medicine; Rivaroxaban; Aspirin; Cohort; Myocardial infarction; Stroke (engine); Internal medicine; Hazard ratio; Warfarin; Surgery; Confidence interval; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009712502,0.00107034,0.0010461,0.0003819635,0.0001299382,0.0007753898,0.000722247,0.0006991986,0.00127683],"category_scores_gemma":[0.01264841,0.000275687,0.00220681,0.0004298275,0.0003131539,0.0004495519,0.000704824,0.0007245395,0.0002060968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004504321,"about_ca_system_score_gemma":0.0005466731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002380136,"about_ca_topic_score_gemma":0.001427296,"domain_scores_codex":[0.9976195,0.001653298,0.0001099074,0.0003095992,0.0002509306,0.00005675753],"domain_scores_gemma":[0.9914128,0.005155383,0.001631146,0.001146936,0.000334909,0.0003187577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06461754,0.000733626,0.7741866,0.0005673597,0.02018696,0.0001478238,0.0002442512,0.09946632,0.001175473,0.0007958567,0.002438209,0.03543996],"study_design_scores_gemma":[0.01323586,0.01409511,0.6834311,0.0001872091,0.01066019,0.0007106796,0.0001898713,0.2674393,0.00215625,0.003899242,0.003810046,0.000185233],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915166,0.001203955,0.003649837,0.0001868938,0.00001875869,0.0001276056,0.002235272,0.00005030111,0.001010796],"genre_scores_gemma":[0.9938555,0.0002316559,0.001895379,0.00009618914,0.00002757784,0.00009653872,0.003473804,0.00001461396,0.0003087858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009712502,"threshold_uncertainty_score":0.05136526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02304786823365794,"score_gpt":0.2479306605782584,"score_spread":0.2248827923446004,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}